Greenleaf Trust’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,319
Closed -$212K 751
2022
Q2
$212K Buy
4,319
+16
+0.4% +$858 ﹤0.01% 662
2022
Q1
$244K Sell
4,303
-26
-0.6% -$1.38K ﹤0.01% 667
2021
Q4
$227K Buy
4,329
+23
+0.5% +$1.25K ﹤0.01% 687
2021
Q3
$258K Buy
4,306
+11
+0.3% +$678 ﹤0.01% 620
2021
Q2
$291K Hold
4,295
﹤0.01% 586
2021
Q1
$282K Hold
4,295
﹤0.01% 573
2020
Q4
$242K Hold
4,295
﹤0.01% 533
2020
Q3
$209K Hold
4,295
﹤0.01% 515
2020
Q2
$239K Hold
4,295
﹤0.01% 459
2020
Q1
$218K Buy
4,295
+45
+1% +$3.02K ﹤0.01% 409
2019
Q4
$329K Hold
4,250
0.01% 383
2019
Q3
$269K Sell
4,250
-175
-4% -$10.9K ﹤0.01% 439
2019
Q2
$259K Sell
4,425
-10
-0.2% -$590 ﹤0.01% 442
2019
Q1
$252K Hold
4,435
﹤0.01% 432
2018
Q4
$220K Hold
4,435
﹤0.01% 430
2018
Q3
$315K Hold
4,435
0.01% 381
2018
Q2
$231K Sell
4,435
-500
-10% -$26.2K ﹤0.01% 442
2018
Q1
$258K Sell
4,935
-272
-5% -$13.8K 0.01% 372
2017
Q4
$305K Buy
5,207
+22
+0.4% +$1.25K 0.01% 330
2017
Q3
$288K Hold
5,185
0.01% 326
2017
Q2
$399K Sell
5,185
-750
-13% -$56.1K 0.01% 234
2017
Q1
$443K Buy
+5,935
New +$431K 0.01% 171

Other funds holding NUVA

Greenleaf Trust's NUVA Position: Q3 2022 in Review

Greenleaf Trust sold out of NuVasive, Inc. (NUVA) in Q3 2022, closing a stake of 4,319 shares — an estimated $212K sold.

Greenleaf Trust first reported a position in NUVA in Q1 2017 and held it in 22 quarters. The position peaked at $443K in Q1 2017. 232 funds tracked by Wall St. Rank hold NUVA as of Q3 2022.

  • Greenleaf Trust reported no remaining NuVasive, Inc. position as of Q3 2022 after selling out during the quarter.
  • Greenleaf Trust sold 4,319 NuVasive, Inc. shares in Q3 2022, an estimated $212K.
  • Greenleaf Trust first reported a position in NuVasive, Inc. in Q1 2017 and held it in 22 quarters.
  • Greenleaf Trust's NuVasive, Inc. position peaked at $443K in Q1 2017.
  • 232 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2022.

Based on Greenleaf Trust's 13F filing for Q3 2022, filed 10 Nov 2022.